What is the recommended dose of lansoprazole?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Dose of Lansoprazole

For pediatric patients (1-17 years), lansoprazole should be dosed at 0.7-3 mg/kg/day, FDA-approved for ages 1-17 years. 1

Pediatric Dosing (Ages 1-17 Years)

The American Academy of Pediatrics guidelines provide clear weight-based dosing for lansoprazole in children 1:

  • Dose range: 0.7-3 mg/kg/day
  • FDA-approved age range: 1-17 years
  • Available formulations:
    • Capsule contents can be sprinkled onto soft foods or select juices
    • Can be administered through nasogastric tube (≥8 French) in juice
    • Strawberry-flavored disintegrating tablet
    • Orally disintegrating tablet via oral syringe or nasogastric tube

Important caveat: Lansoprazole was studied in infants <1 year but was not found to be effective in this age group 2. A multicenter, double-blind, placebo-controlled study in 162 patients aged 1 month to <12 months with symptomatic GERD showed no benefit over placebo. Therefore, do not use lansoprazole in infants under 1 year of age.

Adult Dosing

For GERD and Erosive Esophagitis

Standard dose: 30 mg once daily is the optimal dose for most adult patients 3, 4:

  • Mild-moderate erosive esophagitis (LA grade A/B): 30 mg once daily for 8 weeks produces healing rates of 81-95% 3
  • Severe erosive esophagitis (LA grade C/D): 30 mg once daily, though some patients may require 60 mg daily 3
  • Maintenance therapy: 15 mg once daily is typically sufficient after healing 2

The 30 mg dose demonstrated superior healing rates compared to 15 mg at 4 weeks (81.3% vs 67.6%, p<0.05), while 60 mg offered no additional benefit over 30 mg 3.

For Symptomatic GERD/Heartburn

15 mg once daily is appropriate for uncomplicated heartburn 5, 6:

  • Effective for frequent nighttime heartburn (61.3% of nights without heartburn vs 47.8% with placebo, p<0.0001) 6
  • Provides rapid symptom relief, often within 24 hours 6
  • Can be used for on-demand therapy in self-treating patients

For H. pylori Eradication

30 mg twice daily (equivalent to 45 mg lansoprazole per the potency conversion) as part of triple or quadruple therapy 7:

  • Minimum dose should be equivalent to 40 mg omeprazole twice daily
  • 30 mg lansoprazole = 27 mg omeprazole equivalent 7
  • Duration: 14 days as part of combination regimen

For NSAID-Associated Ulcer Prevention

15 mg once daily is effective for secondary prevention 8:

  • Cumulative ulcer incidence at 12 months: 12.7% with lansoprazole 15 mg vs 36.9% with gefarnate (p<0.0001) 8
  • Suitable for long-term use in patients requiring chronic NSAID therapy

Dosing Timing and Administration

Take 30-60 minutes before meals for optimal effect 9, 10:

  • Unlike newer P-CABs, lansoprazole requires premeal dosing to coincide with active proton pumps
  • Maximal acid inhibition achieved when food consumed within 30 minutes of dosing
  • For twice-daily dosing: administer before breakfast and dinner

Special Populations

Severe Hepatic Impairment (Child-Pugh Class C)

Reduce dose to 15 mg once daily 2:

  • No adjustment needed for mild (Class A) or moderate (Class B) hepatic impairment
  • Exposure increases significantly in severe hepatic disease

Patients with Hiatal Hernia

May require 60 mg daily for adequate acid suppression 11:

  • 30 mg daily normalized esophageal acid exposure in 70% of patients overall
  • In patients with hiatal hernia, 100% required 60 mg daily for normalization
  • In patients without hiatal hernia, 30 mg was effective in 100% of cases

Duration Considerations

  • Acute treatment: 8 weeks for erosive esophagitis 3
  • Maintenance: Can continue long-term at reduced dose (typically 15 mg daily) 2
  • Do not exceed recommended duration in pediatric patients due to potential bone and cardiac valve effects seen in juvenile animal studies 2

Common Pitfalls to Avoid

  1. Do not use in infants <1 year - proven ineffective and not FDA-approved 2
  2. Do not underdose in H. pylori treatment - requires twice-daily dosing at higher doses 7
  3. Do not forget premeal timing - unlike P-CABs, lansoprazole requires administration 30-60 minutes before meals 9
  4. Do not assume 15 mg is adequate for erosive esophagitis - 30 mg is the optimal dose for healing 3, 4

References

Research

Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.

Expert opinion on pharmacotherapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.